We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.22 | -0.15% | 149.70 | 149.89 | 147.82 | 149.89 | 6,532,721 | 00:38:06 |
From May 2019 to May 2024
By Eric Sylvers
The European Union Medicines Agency said a warning should be added to the product information of the Johnson & Johnson Covid-19 vaccine that unusual blood clots with low blood platelets is a very rare possible side effect. The agency said that the overall benefits of the J&J shot outweigh the possible side effects and that healthcare professionals should be on the lookout for the combination of blood clots and low platelet levels.
(More to come)
Write to Eric Sylvers at eric.sylvers@wsj.com
(END) Dow Jones Newswires
April 20, 2021 10:56 ET (14:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
